Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06622252 · ClinicalTrials.gov registry record · NA

Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer

A NA study of Quality of Life and Pediatric Cancer, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT06622252 is a NA study of Quality of Life and Pediatric Cancer that has completed, run by University of California, Irvine. The registered enrollment target is 33 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06622252, a NA study of Quality of Life and Pediatric Cancer, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if a culturally relevant caregiver intervention is effective in decreasing stress and improving quality of life in Spanish speaking Latino caregivers of children diagnosed with cancer compared to a control group.

Interventions

  • OTHER 13-week session program

Study Locations (1)

California

  • CHOC Children's - Orange

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2021-08-20
Est. Completion 2025-07-31
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT06622252

The ClinicalTrials.gov registry entry for NCT06622252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (93% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which 13-week session program is the first listed.

NCT06622252 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06622252 about?

NCT06622252 is a clinical study titled "Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer". The purpose of this study is to determine if a culturally relevant caregiver intervention is effective in decreasing stress and improving quality of life in Spanish speaking Latino caregivers of children diagnosed with cancer compared to a control group.

What is the current status of trial NCT06622252?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-08-20. Estimated completion is 2025-07-31.

What conditions does trial NCT06622252 study?

This clinical trial studies the following conditions: Quality of Life, Pediatric Cancer, Caregiver Burden.

What interventions are being tested in trial NCT06622252?

The interventions under investigation include: 13-week session program (OTHER).

Who is sponsoring clinical trial NCT06622252?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06622252 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.